Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1. (Q37942011)

25 August 2017

1 reference

title

Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1. (English)

1 reference

25 August 2017

1 reference

1 reference

Junlin Jiang

1

1 reference

25 August 2017

Meiling Yan

series ordinal

2

1 reference

25 August 2017

Jawahar L Mehta

series ordinal

3

1 reference

25 August 2017

Changping Hu

series ordinal

4

1 reference

25 August 2017

1 October 2011

1 reference

Cardiovascular Drugs and Therapy

25 August 2017

1 reference

25 August 2017

25

1 reference

25 August 2017

461-468

1 reference

25 August 2017

5

1 reference

Mechanisms of angiogenesis

25 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Plaque neovascularization and antiangiogenic therapy for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Diabetes mellitus and risk of breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

PDGF and vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiopoietin-1 induces sprouting angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Androgens, angiogenesis and cardiovascular regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Gene therapy and angiogenesis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Magnetic resonance imaging of brain angiogenesis after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Toll-like receptors in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Vascular involvement in rheumatic diseases: 'vascular rheumatology'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Therapeutic angiogenesis in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Normalization of the vasculature for treatment of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

The vulnerable and unstable atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiogenesis in atherosclerosis: gathering evidence beyond speculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Angiogenesis in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Fighting cancer by attacking its blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

The angiogenic switch in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

The history of the angiogenic switch concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

HIF-1α in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

PDGF/VEGF system activation and angiogenesis following initial post ovariectomy meningeal microvessel loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Targeting hypoxia and angiogenesis through HIF-1alpha inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

VEGF as a key mediator of angiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Oxidative stress and oxidative damage in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Novel function of ascorbic acid as an angiostatic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Antiangiogenic and antimitotic effects of aspirin in hypoxia–reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Potential involvement of LOX-1 in functional consequences of endothelial senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

ACP Journal Club. Meta-analysis: aspirin reduces risk for colon cancer and related mortality at 20 years, particularly when taken for ≥ 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Statins and angiogenesis: is it about connections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6343-3

10.1007/S10557-011-6343-3

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference